S
Stephen L. Kopecky
Researcher at Mayo Clinic
Publications - Â 144
Citations - Â 10783
Stephen L. Kopecky is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 43, co-authored 139 publications receiving 10107 citations. Previous affiliations of Stephen L. Kopecky include University of Rochester & Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Randomised Clinical Trial
Joseph L. Blackshear,Vickie S. Baker,F. Rubino,Robert E. Safford,Gary E. Lane,T. Flipse,J. Malouf,Randall C. Thompson,Richard Webel,Greg C. Flaker,L. Young,David C Hess,G. Friedman,R. Burger,John H. McAnulty,Bruce M. Coull,Christy Marchant,J. Timberg,C. Janzik,G. Giraud,B. Halperin,J. Kron,M. Wynn,M. Raitt,David C. Anderson,Richard W. Asinger,S. M. Newburg,J. Fifield,S. R. Bundlie,Richard L. Koller,R. D. Tarrel,C. Dick,J. M. Haugland,C. R. Jorgensen,Anne D. Leonard,Merrill C. Kanter,Diane H. Solomon,Miguel Zabalgoitia,D. Mego,John E. Carter,S. Y. Boyd,Bradley S. Boop,D. LaLonde,R. Modlin,William R. Logan,B. J. Green,William P. Hamilton,L. Mezei,S. Riggio,George Feldman,Arthur D. Hayward,R. Strauss,W. Anderson,J. Grover,M. McKenzie,P. Hart-McArthur,M. Gramberg,H. Houston,Jonathan L. Halperin,E. B. Rothauf,Jesse Weinberger,Martin E. Goldman,Andreas Laupacis,K. L. Chan,P. Bourque,J. Biggs,A. Ives,William M. Feinberg,Karl B. Kern,Gregory D. Pennock,Paul E. Fenster,B. J. Huerta,J. Ohm,Howard C. Dittrich,C. Kerridge,W. Keen,M. Swenson,Stephen L. Kopecky,Scott C. Litin,David O. Wiebers,Anne E. Holland,Ronald D. Brown,B. K. Khandheria,I. Meissner,K. R. Tucker,Robert M. Rothbart,J. Torelli,J. Schmidt,D. Murray,R. S. Ruzich,H. Loutfi,Christopher P. Appleton,T. Ingall,L. Carlson,D. Wilson,M. Dunn,B. Nolte,C. Edwards,A. Dick,L. A. Price,Denise L. Janosik,P. Bjerregaard,A. Quattromani,L. Schiller,Arthur J. Labovitz,C. Burch,B. J. Parks,D. Thompson,L. Berarducci,S. Carey,A. Vigil,Rodney H. Falk,N. Battinelli,M. McNeil,R. Davidoff,Sheilah Bernard,P. Bergethon,L. Fiori,Gregory W. Albers,E. Atwood,J. Clark,D. Tong,Midori A. Yenari,V. Froelicker,H. Lutsep,N. H. Hock,S. Quaglietti,S. Kemp,M. A. Alpert,J. F. Rothrock,C. H. Hupp,C. V. Massey,W. J. Hamilton,V. T. Miller,J. Fox,RichardA. Kronmal,Ruth McBride,E. Nasco,Lesly A. Pearce,K. Fletcher,Jodi Koehler,Robert G. Hart,David G. Sherman,R. L. Talbert,P. A. Heberling,C. Kajzer,EG Bovill,D. Geffken,E. Cornell,S. Nightingale,S. P. Kelsy,David E. Levy,J. D. Marsh,K. M.A. Welch,John R. Marler,M. D. Walker +155 more
TL;DR: Low-intensity, fixed-dose warfarin plus aspirin in this regimen is insufficient for stroke prevention in patients with non-valvular AF at high-risk for thromboembolism; adjusted-doseWarfarin (target INR 2.0-3.0) importantly reduces stroke for high- risk patients.
Journal ArticleDOI
The natural history of lone atrial fibrillation. A population-based study over three decades.
Stephen L. Kopecky,Bernard J. Gersh,Michael D. McGoon,Jack P. Whisnant,David R. Holmes,Duane M. Ilstrup,Robert L. Frye +6 more
TL;DR: It is concluded that lone atrial fibrillation in patients under the age of 60 at diagnosis is associated with a very low risk of stroke, and routine anticoagulation may not be warranted.
Journal ArticleDOI
Idiopathic Short QT Interval:A New Clinical Syndrome?
Ihor Gussak,Pedro Brugada,Josep Brugada,R. Scott Wright,Stephen L. Kopecky,Bernard R. Chaitman,Preben Bjerregaard +6 more
TL;DR: This report describes three members of one family demonstrating this ECG phenomenon, associated in the 17-year-old with several episodes of paroxysmal atrial fibrillation requiring electrical cardioversion, and considers the possible arrhythmogenic potential of the short QTI.
Journal ArticleDOI
Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination
R. Scott Wright,Guy S. Reeder,Charles A. Herzog,Robert C. Albright,Brent A. Williams,David L. Dvorak,Wayne L. Miller,Joseph G. Murphy,Stephen L. Kopecky,Allan S. Jaffe +9 more
TL;DR: Outcomes in patients with acute MI and any degree of renal failure, including end-stage renal disease, were compared to determine whether treatment of these patients differs from that of patients with normal renal function and to determine the extent to which treatment factors explain differences in prognosis.
Journal ArticleDOI
A Clinical Trial of a Chest-Pain Observation Unit for Patients with Unstable Angina
Michael E. Farkouh,Peter A. Smars,Guy S. Reeder,Alan R. Zinsmeister,Roger W. Evans,Thomas D. Meloy,Stephen L. Kopecky,Marvin R. Allen,Thomas G. Allison,Raymond J. Gibbons,Sherine E. Gabriel +10 more
TL;DR: A CPU located in the emergency department can be a safe, effective, and cost-saving means of ensuring that patients with unstable angina who are considered to be at intermediate risk for cardiovascular events receive appropriate care.